Compositions and methods are described that provide cellulosic and non-cellulosic fabrics with durable antimicrobial properties. Application of a coating that includes polyhexamethylene biguanide, polyethylene glycol, and a binder to a fabric followed by drying and curing was found to provide antimicrobial properties that are retained through over 100 washings under aggressive hospital washing conditions. In addition, tactile properties and tear resistance of the treated fabrics are maintained or improved.

Methods of making polycationic nanofibers by grafting cationic polymers onto electrospun neutral nanofibers and polycationic nanofibers produced by the methods are provided herein. In addition, methods of using the polycationic nanofibers to reduce inflammation, to adsorb anionic compounds such as heparin or nucleic acids, to inhibit the growth of microbes or inhibit the formation of a biofilm are also provided. The polycationic nanofibers may be in a mesh and may be included in a medical device, wound dressing, bandage, or as part of a graft.

A textile structure including one or more layers of warp yarns interwoven with one or more layers of weft yarns, a durable thermoregulating coating, and a binder that chemically bonds the durable thermoregulating coating to the textile structure. The warp yarns and/or weft yarns include polyester yarns. A method for manufacturing a textile structure includes weaving one or more layers of warp yarns with one or more layers or weft yarns to form a woven textile structure, brushing the textile structure at least two times, applying a binder to the textile structure, and applying a durable thermoregulating coating to the textile structure such that the binder chemically bonds the durable thermoregulating coating to the textile structure. The method may also include heat setting and curing the textile structure to fix the durable thermoregulating coating permanently onto the textile structure.

An ink comprises (i) a carrier; (ii) graphene and/or graphene oxide particles dispersed in the carrier; and (iii) a viral active and/or anti-microbial component adhered to the graphene and/or graphene oxide particles.